Motorola Solutions has introduced SafetyCam, a new wearable camera system designed to improve security for retail employees. This device integrates with existing security systems, offering real-time situational awareness and incident documentation. It features a high-definition camera, microphone, and emergency button, archiving footage to the cloud for incident reporting and evidence.

Franklin Templeton has launched the Franklin BSP CLO ETF (YCLO), an actively managed ETF investing predominantly in investment-grade collateralized loan obligation (CLO) debt tranches across U.S. and European markets. The fund aims for capital preservation and current income, drawing on Benefit Street Partners' structured credit platform and its global relative value approach. YCLO offers investors access to an institutional asset class with floating-rate income, structural protections, and diversification potential within fixed-income portfolios.

Chai Discovery has announced a license agreement with Pfizer, providing the biopharmaceutical company with access to its AI platform, including the advanced Chai-3 model and a custom solution leveraging Pfizer's proprietary data. This collaboration aims to accelerate drug discovery by enabling Pfizer scientists to design new biomolecules and pursue challenging targets using AI, thereby compressing development timelines. The agreement highlights the growing adoption of frontier AI models in the pharmaceutical industry to enhance drug research and development.

Pomerantz LLP has filed a class action lawsuit against FS KKR Capital Corp. (NYSE: FSK) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or other unlawful business practices, stemming from significant declines in the company's net asset value and earnings per share reported in Q2 and Q4 2025, which led to sharp drops in stock price and a dividend cut. Investors who purchased FSK KRR securities during the class period have until July 3, 2026, to apply for lead plaintiff.

Pomerantz LLP has launched an investigation into potential securities fraud or unlawful business practices by Biogen Inc. and its officers/directors. This follows a significant drop in Biogen's stock price on May 14, 2026, after the company announced "compelling" Phase 2 study results for its Alzheimer's therapy, diranersen (BIIB080), which nonetheless missed its primary endpoint. Investors are encouraged to contact the law firm for more information regarding joining a potential class action.

Arch Insurance North America has announced significant leadership changes within its wholesale platform, promoting Jason Conkin to Division President of Wholesale Property & Casualty. These changes aim to unify E&S Property and E&S Casualty operations and strengthen collaboration with wholesale producers. Valerie Turpin, Division President of Property, will retire in July.

GE HealthCare has received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software, an AI-enabled tool designed to assist with treatment planning in radiation oncology by automating the time-intensive process of manual contouring. This approval includes a Predetermined Change Control Plan, which will allow for quicker iterations and enhancements to the software. The new technology aims to improve efficiency and accuracy in radiation therapy planning, giving care teams more time to focus on individualized patient treatment plans.

Mirum Pharmaceuticals and Incyte announced that pivotal Phase 2 results for zilurgisertib, an investigational ALK2 inhibitor for fibrodysplasia ossificans progressiva (FOP), will be presented at ENDO 2026. The data from the placebo-controlled PROGRESS study's Cohort 1 formed the basis for the New Drug Application (NDA), which has been accepted by the FDA for Priority Review with a PDUFA date of September 26, 2026. This presentation marks an important step in advancing a potential new treatment option for the rare genetic disease FOP.

Aptiv's Winchester Interconnect has launched a new VITA 67.2 RF connector product line designed for high-density aerospace and defense systems. These connectors can house up to eight RF channels within a single Open VPX slot, significantly reducing external cabling and facilitating faster field repairs. This innovation addresses the growing demand for increased bandwidth and channel density in modern defense electronics while adhering to tight size, weight, and power budgets.

Dollar General reported strong Q1 FY2027 results, with EPS beating expectations and net sales rising 3.4% year-over-year, driven by increased customer traffic and same-store sales. The company expanded its operating margin by 40 basis points and raised its full-year FY2026 EPS guidance, indicating continued earnings expansion. TIKR's valuation model suggests a significant upside for Dollar General stock, contingent on sustained margin recovery and strategic program success.